microfibril associated protein 1 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored MFAP1P1 profile across patient tissues and cancer cell-line models. MFAP1P1 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, MFAP1P1 is differentially expressed in 11, with the highest sampling consensus in LUSC. Additionally, MFAP1P1 RNA expression shows 16,623 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight COAD, LUSC, and THYM as cancer lineages where MFAP1P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MFAP1P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MFAP1P1 survival associations across molecular data types. MFAP1P1 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MFAP1P1 RNA expression–survival associations across cancer types. High MFAP1P1 expression shows unfavorable associations in COAD, but favorable associations in UCS, KIRP, HNSC, PAAD and SKCM. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .009). Together, the overview and detailed table identify COAD as the clearest survival context for MFAP1P1 RNA expression.
This table summarizes MFAP1P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in LUSC for RNA.
This table ranks reproducible tumor–normal expression differences for MFAP1P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MFAP1P1 shows lower tumor expression in LUSC, UCEC, BRCA and KICH and higher tumor expression in LIHC and CHOL. The LUSC box plot shows higher MFAP1P1 RNA expression in normal versus tumor tissue (log2 FC = −0.195, t-test p < 0.001).
This table shows molecular features associated with MFAP1P1 in patient tissues and cancer cell lines. In patient samples, MFAP1P1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
